SK287324B6 - Trojsodná soľ kyseliny 4-amino-1-hydroxybutylidén-1,1- bisfosfónovej - Google Patents

Trojsodná soľ kyseliny 4-amino-1-hydroxybutylidén-1,1- bisfosfónovej Download PDF

Info

Publication number
SK287324B6
SK287324B6 SK5103-2005A SK51032005A SK287324B6 SK 287324 B6 SK287324 B6 SK 287324B6 SK 51032005 A SK51032005 A SK 51032005A SK 287324 B6 SK287324 B6 SK 287324B6
Authority
SK
Slovakia
Prior art keywords
trisodium
alendronate
water
amino
hydroxybutylidene
Prior art date
Application number
SK5103-2005A
Other languages
English (en)
Slovak (sk)
Other versions
SK51032005A3 (sk
Inventor
Jana Dostálová
Aleš Halama
Josef Jirman
Hana Petříčková
Original Assignee
Zentiva, A. S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva, A. S. filed Critical Zentiva, A. S.
Publication of SK51032005A3 publication Critical patent/SK51032005A3/sk
Publication of SK287324B6 publication Critical patent/SK287324B6/sk

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK5103-2005A 2004-12-28 2005-12-15 Trojsodná soľ kyseliny 4-amino-1-hydroxybutylidén-1,1- bisfosfónovej SK287324B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20041249A CZ297262B6 (cs) 2004-12-28 2004-12-28 Trisodná sul kyseliny 4-amino-1-hydroxybutyliden-1,1-bisfosfonové

Publications (2)

Publication Number Publication Date
SK51032005A3 SK51032005A3 (sk) 2006-07-07
SK287324B6 true SK287324B6 (sk) 2010-07-07

Family

ID=36658574

Family Applications (1)

Application Number Title Priority Date Filing Date
SK5103-2005A SK287324B6 (sk) 2004-12-28 2005-12-15 Trojsodná soľ kyseliny 4-amino-1-hydroxybutylidén-1,1- bisfosfónovej

Country Status (2)

Country Link
CZ (1) CZ297262B6 (cs)
SK (1) SK287324B6 (cs)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1107974E (pt) * 1998-08-27 2006-10-31 Teva Pharma Novas formas de hidratos de alendronato de sodio, processos para a sua producao e suas composicoes farmaceuticas
US6963008B2 (en) * 1999-07-19 2005-11-08 Teva Pharmaceutical Industries Ltd. Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
GB2383042A (en) * 2001-10-18 2003-06-18 Cipla Ltd Amorphous alendronate sodium
ITMI20020146A1 (it) * 2002-01-29 2003-07-29 Lyogen Ltd Alendronato monosodico amorfo e processo per la sua preparazione

Also Published As

Publication number Publication date
SK51032005A3 (sk) 2006-07-07
CZ20041249A3 (cs) 2006-08-16
CZ297262B6 (cs) 2006-10-11

Similar Documents

Publication Publication Date Title
US10519176B2 (en) Crystalline forms
CA2477350C (en) Novel crystalline forms of the anti-cancer compound zd1839
JP2009143955A (ja) アレンドロネートナトリウムの新規水和物型、その製造方法、及びその医薬組成物
EP3969449A1 (en) New crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as raf inhibitors for the treatment of cancer
IL208152A (en) Processes for the preparation of supernatant tosylate crystalline form iii, supernatant tosylate methanol solvate and supernatant tozylate ethanol solvate
EP1723157B1 (en) Amorphous forms of risedronate monosodium
KR20120052381A (ko) 프라수그렐 염의 결정형
WO2007074475A2 (en) Novel polymorphic forms of ibandronate
EP2710009B1 (en) Novel crystalline asenapine hydrochloride salt forms
US20220002302A1 (en) Novel polymorphs of acalabrutinib, a bruton's tyrosine kinase inhibitor
EP2710008A1 (en) Novel crystalline salts of asenapine with organic di-acids and tri-acids
SK287324B6 (sk) Trojsodná soľ kyseliny 4-amino-1-hydroxybutylidén-1,1- bisfosfónovej
EP2397458A1 (en) Organic salts and co-crystals of phenylbutyric acid
SK50702005A3 (sk) Trisodná soľ kyseliny 4-amino-1-hydroxybutylidén-1,1- bisfosfónovej
EP1928889A1 (en) Pharmaceutically acceptable salts and hydrates of risedronic acid
EP3455229B1 (en) Novel crystalline forms
EP3517529B1 (en) Salt of quinazoline derivative, preparation method therefor and application thereof
US20060270633A1 (en) Crystalline form of fosinopril calcium
JP2004091442A (ja) 水溶性クエン酸マグネシウム含水塩およびその製法
EP1702924A2 (en) Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
WO2013054146A1 (en) New co crystals useful in the preparation of pharmaceutical compositions

Legal Events

Date Code Title Description
TA4A Addition of inventor(s)

Effective date: 20101124

TC4A Change of owner's name

Owner name: ZENTIVA, K.S., PRAHA, DOLNI MECHOLUPY, CZ

Effective date: 20120524

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20121215